In-Hospital and 1-Year Outcomes Among Percutaneous Coronary Intervention Patients With Chronic Kidney Disease in the Era of Drug-Eluting Stents-Reference-Cited by-同舟云学术

In-Hospital and 1-Year Outcomes Among Percutaneous Coronary Intervention Patients With Chronic Kidney Disease in the Era of Drug-Eluting Stents

Published:2009-01 Issue:1 Volume:2 Page:37-45
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Latif Faisal,Kleiman Neal S.,Cohen David J.,Pencina Michael J.,Yen Chen-Hsing,Cutlip Donald E.,Moliterno David J.,Nassif Deborah,Lopez John J.,Saucedo Jorge F.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States,2006

2. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey;Coresh;Am J Kidney Dis,2003

3. Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era?;Rubenstein;Circulation,2000

4. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions;Best;J Am Coll Cardiol,2002

5. Short and long-term outcome of percutaneous trans-luminal coronary angioplasty in chronic dialysis patients;Kahn;Am Heart J,1990

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clopidogrel Versus Aspirin as Chronic Maintenance Antiplatelet Monotherapy in Patients After Percutaneous Coronary Intervention With Chronic Kidney Disease: A Post Hoc Analysis of the HOST‐EXAM Trial;Journal of the American Heart Association;2024-09-09

2. Long-term outcomes of high bleeding risk patients undergoing percutaneous coronary intervention: a Korean nationwide registry;European Heart Journal;2024-07-23

3. Angiographic Characteristics and Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing Impella-Supported High-Risk Percutaneous Coronary Intervention: Insights From the cVAD PROTECT III Study;Circulation: Cardiovascular Interventions;2024-07

4. Investigation of smoking on the antiplatelet response to clopidogrel: Unravelling the smoker’s paradox;Pathology - Research and Practice;2024-05

5. Ischemic and Bleeding Outcomes in Patients Who Underwent Percutaneous Coronary Intervention With Chronic Kidney Disease or Dialysis (from a Japanese Nationwide Registry);The American Journal of Cardiology;2023-05